BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16549836)

  • 1. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck.
    Liauw SL; Mancuso AA; Amdur RJ; Morris CG; Villaret DB; Werning JW; Mendenhall WM
    J Clin Oncol; 2006 Mar; 24(9):1421-7. PubMed ID: 16549836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?
    Yeung AR; Liauw SL; Amdur RJ; Mancuso AA; Hinerman RW; Morris CG; Villaret DB; Werning JW; Mendenhall WM
    Cancer; 2008 Mar; 112(5):1076-82. PubMed ID: 18186495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma.
    Ojiri H; Mendenhall WM; Stringer SP; Johnson PL; Mancuso AA
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):420-8. PubMed ID: 11872288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
    Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure.
    Liauw SL; Mancuso AA; Morris CG; Amdur RJ; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1017-21. PubMed ID: 17145530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
    Rogers JW; Greven KM; McGuirt WF; Keyes JW; Williams DW; Watson NE; Geisinger K; Cappellari JO
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):694-7. PubMed ID: 14967422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planned postradiotherapy neck dissection: Rationale and clinical outcomes.
    Sewall GK; Palazzi-Churas KL; Richards GM; Hartig GK; Harari PM
    Laryngoscope; 2007 Jan; 117(1):121-8. PubMed ID: 17202940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
    Yao M; Luo P; Hoffman HT; Chang K; Graham MM; Menda Y; Tan H; Buatti JM
    Am J Clin Oncol; 2007 Jun; 30(3):264-70. PubMed ID: 17551303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy.
    Civantos FJ; Moffat FL; Goodwin WJ
    Laryngoscope; 2006 Mar; 112(3 Pt 2 Suppl 109):1-15. PubMed ID: 16540925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer.
    Greven KM; Williams DW; Browne JD; McGuirt WF; White DR; D'Agostino RB
    Am J Clin Oncol; 2008 Apr; 31(2):169-72. PubMed ID: 18391602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
    Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy.
    Ojiri H; Mancuso AA; Mendenhall WM; Stringer SP
    AJNR Am J Neuroradiol; 2002; 23(10):1627-31. PubMed ID: 12427611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.